Managing dystrophinopathic cardiomyopathy

L Politano, G Nigro - Expert Opinion on Orphan Drugs, 2016 - Taylor & Francis
Introduction: Dystrophinopathies, due to mutations in the dystrophin gene, include four
different phenotypes: Duchenne muscular Dystrophy (DMD), Becker muscular dystrophy …
被引用次数：11 相关文章

[引用][C] Managing dystrophinopathic cardiomyopathy

L Politano, G Nigro - Expert Opinion on Orphan Drugs, 2016 - cir.nii.ac.jp
Managing dystrophinopathic cardiomyopathy | CiNii Research CiNii 国立情報学研究所 学術
情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本を …

Managing dystrophinopathic cardiomyopathy

L Politano, G Nigro - EXPERT OPINION ON ORPHAN DRUGS, 2016 - iris.unicampania.it
Introduction: Dystrophinopathies, due to mutations in the dystrophin gene, include four
different phenotypes: Duchenne muscular Dystrophy (DMD), Becker muscular dystrophy …